SpecialtiesGeorge Thompson, M.D. 
Clinical/Research Interests
Dr. Thompson is Assistant Professor of Medicine at the University of California, Davis, School of Medicine with a joint appointment in the Departments of Medical Microbiology and Immunology, and Internal Medicine, Division of Infectious Diseases. Dr. Thompson specializes in the care of patients with invasive fungal infections and has research interest in fungal diagnostics and host immunogenetics. His current research focuses on the host-pathogen interaction of humans and both Coccidioides spp. (the agent of "Valley Fever"), and Cryptococcus spp.
Dr. Thompson has substantial expertise in the care of patients with fungal diseases and serves on the Mycoses Study Group Education Committee which is responsible for the dissemination of materials and knowledge to clinicians across the country to improve the care of patients with fungal infections. He additionally was recently appointed to the Coccidioidomycosis Study Group and the Infectious Diseases Society of America (IDSA) Journal Club providing editorials in the monthly internationally disseminated IDSA Newsletter.
Title:
Specialty:
Education:
Columbia, Missouri
M.D. 2003
Residency:
San Antonio, Texas
2007
Internal Medicine
Fellowships:
San Antonio, Texas
2009
Infectious Diseases
Board Certifications:
American Board of Internal Medicine, 2006
Professional Memberships:
American Medical Association
American Society for Microbiology
Coccidioidomycosis Study Group
Education Committee
HIV Medicine Association
Infectious Disease Society of America
Infectious Disease Society of America
International Society for Human and Animal Mycoses
International Society for Infectious Diseases
Mechanisms in Fungal Infections, Editorial Board
Mycoses Study Group
Northern California American College of Physicians
South Texas American College of Physicians
South Texas American College of Physicians
Honors and Awards:
Outstanding Clinical Faculty Teaching Award, 2007
Texas Infectious Disease Society Poster Presentation, First Place, 2006
Resident Humanism and Excellence in Teaching Award, 2005
Alpha Omega Alpha, 2003
Outstanding Achievement in Internal Medicine Award, 2003
Humanism in Medicine Award, 2003
Select Recent Publications:
Thompson GR III, Lunetta JM, Johnson SM, Taylor S, Bays D, Cohen SH, Pappagianis D. Early Treatment with Fluconazole may Abrogate the Development of IgG Antibodies in Coccidioidomycosis. Clinical Infectious Diseases 2011; Sep:53(6):e20-4. PMID:21865185
Lat A, Thompson GR III. Update on the Optimal Use of Voriconazole for Invasive Fungal Infections. Infection and Drug Resistance. 2011;4:43-53. PMID:21694908
Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive Aspergillosis Following H1N1 Influenza. Emerging Infectious Diseases. 2010; Jun; 16(6):971-3.
Thompson GR III, Patel PK, Erlandsen J, Redding SW, Patterson TF. Oropharyngeal Candidiasis in the Era of Highly Active Antiretroviral Therapy. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2010; Apr: 109(4):488-95.
Thompson GR III, Wiederhold NP. Isavuconazole: A Comprehensive Review of Existing Data. Mycopathologia. 2010 Nov;170(5):291-313. PMID:20524153
Cadena J, Thompson GR III, Ho T, Medina E, Hughes D, Patterson TF. Immune Reconstitution Inflammatory Syndrome (IRIS) Following Cessation of the TNF-a Blocker Adalimumab in Cryptococcal Pneumonia. Diagnostic Microbiology and Infectious Diseases. 2009; July; 64(3):327-330.
Thompson GR III, Wiederhold NP, Sutton DA, Fothergill AW, Patterson TF. In Vitro Activity of Isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces, and Pichia Species. The Journal of Antimicrobial Chemotherapy. 2009; Jul; 64(1):79-83.
Thompson GR III, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS. Posaconazole Therapeutic Drug Monitoring (TDM) - A Reference Laboratory Experience. Antimicrobial Agents and Chemotherapy. 2009; May; 53(5):2223-4.
Thompson GR III, Lewis JS II. Pharmacology and clinical use of voriconazole.Expert Opinion on Drug Metabolism and Toxicology. 2009;6(1):83-94.
Thompson GR III, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal Susceptibility Among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 2009; Jan: 53(1):309-311.
